Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serpin family B member 7 (SERPINB7) encodes a serine protease inhibitor that is part of the serpin superfamily, with primary expression in the skin and kidney[3][9]. SERPINB7 acts as an endogenous inhibitor of Lys-specific proteases and is implicated in maintaining epidermal homeostasis, regulating keratinocyte differentiation, and contributing to the integrity of the epidermal barrier[2][3]. Loss-of-function mutations lead to epidermal barrier defects and are causative for autosomal recessive Nagashima-type palmoplantar keratosis, with upregulation observed in psoriatic skin and mesangial expansion in kidney disease[2][3][7]. SERPINB7's biological and pathophysiological roles make it a candidate therapeutic target in inflammatory skin diseases and certain nephropathies, although no direct drugs, mechanisms, or major safety liabilities have been reported to date[2][3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serpin family B member 7 (SERPINB7).